Eur Respir J 2004; 23:916-920
Copyright ©ERS Journals Ltd 2004
High altitude impairs nasal transepithelial sodium transport in HAPE-prone subjects
C. Sartori1,
H. Duplain1,
M. Lepori1,
M. Egli1,
M. Maggiorini2,
P. Nicod1 and
U. Scherrer1
1 Dept of Internal Medicine and the Botnar Center for Clinical Research, Centre Hospitalier Universitaire Vaudois, Lausanne, and 2 Dept of Internal Medicine, University of Zurich, Zurich, Switzerland
CORRESPONDENCE: U. Scherrer, Dept of Internal Medicine, BH 10.642, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland. Fax: 41 213140928, E-mail: Urs.Scherrer@chuv.hospvd.ch
Keywords: Alveolar fluid clearance, high altitude, hypoxia, pulmonary oedema, transepithelial sodium transport
Received: October 15, 2003
Accepted January 11, 2004
This study was supported by grants from the Swiss National Science Foundation (32.46797.96 and 3238-051157.97), the Placide Nicod Foundation, the Emma Muschamp Foundation and the International Olympic Committee.
High-altitude pulmonary oedema (HAPE) occurs in predisposed individuals at altitudes >2,500 m. Defective alveolar fluid clearance secondary to a constitutive impairment of the respiratory transepithelial sodium transport contributes to its pathogenesis. Hypoxia impairs the transepithelial sodium transport in alveolar epithelial type II cells in vitro. If this impairment is also present in vivo, high-altitude exposure could aggravate the constitutive defect in sodium transport in HAPE-prone subjects, and thereby further facilitate pulmonary oedema.
Therefore, the aim of the current study was to measure the nasal potential difference (PD) in 21 HAPE-prone and 29 HAPE-resistant subjects at low altitude and 30 h after arrival at high altitude (4,559 m).
High-altitude exposure significantly decreased the mean±sd nasal PD in HAPE-prone (18.0±6.2 versus 12.5±6.8 mV) but not in HAPE-resistant subjects (25.6±9.4 versus 22.9±9.2 mV). This altitude-induced decrease was not associated with an altered amiloride-sensitive fraction, but was associated with a significantly lower amiloride-insensitive fraction of the nasal PD.
These findings provide evidence in vivo that an environmental factor may impair respiratory transepithelial sodium transport in humans. They are consistent with the concept that in high-altitude pulmonary oedema-susceptible subjects, the combination of a constitutive and an acquired defect in this transport mechanism facilitates the development of pulmonary oedema during high-altitude exposure.
This article has been cited by other articles:

|
 |

|
 |
 
K. Kunzelmann, J. Sun, J. Meanger, N. J. King, and D. I. Cook
Inhibition of Airway Na+ Transport by Respiratory Syncytial Virus
J. Virol.,
April 15, 2007;
81(8):
3714 - 3720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Allemann, D. Hutter, E. Lipp, C. Sartori, H. Duplain, M. Egli, S. Cook, U. Scherrer, and C. Seiler
Patent Foramen Ovale and High-Altitude Pulmonary Edema
JAMA,
December 27, 2006;
296(24):
2954 - 2958.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Maggiorini
High altitude-induced pulmonary oedema
Cardiovasc Res,
October 1, 2006;
72(1):
41 - 50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Litvan, A. Briva, M. S. Wilson, G. R. S. Budinger, J. I. Sznajder, and K. M. Ridge
beta-Adrenergic Receptor Stimulation and Adenoviral Overexpression of Superoxide Dismutase Prevent the Hypoxia-mediated Decrease in Na,K-ATPase and Alveolar Fluid Reabsorption
J. Biol. Chem.,
July 21, 2006;
281(29):
19892 - 19898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jain and J. I. Sznajder
Effects of Hypoxia on the Alveolar Epithelium
Proceedings of the ATS,
October 1, 2005;
2(3):
202 - 205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Bartsch, H. Mairbaurl, M. Maggiorini, and E. R. Swenson
Physiological aspects of high-altitude pulmonary edema
J Appl Physiol,
March 1, 2005;
98(3):
1101 - 1110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Mairbaurl, N. Mason, and P. Bartsch
Nasal potentials at high altitude
Eur. Respir. J.,
February 1, 2005;
25(2):
394 - 395.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Sartori, M. Egli, and U. Scherrer
From the authors
Eur. Respir. J.,
February 1, 2005;
25(2):
395 - 396.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Egli, H. Duplain, M. Lepori, S. Cook, P. Nicod, E. Hummler, C. Sartori, and U. Scherrer
Defective respiratory amiloride-sensitive sodium transport predisposes to pulmonary oedema and delays its resolution in mice
J. Physiol.,
November 1, 2004;
560(3):
857 - 865.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the European Respiratory Society.
|